Ads
related to: biotechnology
Search results
GlycoMimetics (NASDAQ:GLYC) Now Covered by Analysts at StockNews.com
ETF DAILY NEWS· 5 days agoStockNews.com assumed coverage on shares of GlycoMimetics (NASDAQ:GLYC – Free Report) in a research note released on Wednesday. The firm issued a sell rating on the biotechnology< ...
Semiconductors Shine, But Outlook for Other Sectors Remains Mixed | Investing.com
Investing.com· 1 day agoStocks Analysis by Michele Schneider covering: US Small Cap 2000, iShares Biotechnology ETF, NVIDIA...
From A(I) to (Gen) Z, Writing the Future of Beauty at the WWD Beauty CEO Summit
WWD· 8 hours agoBeauty is a big — and ever more competitive — business, but gather together 400 or so industry...
Long-term intravital subcellular imaging with confocal scanning light-field microscopy - Nature ...
Nature· 1 day agoA confocal microscopy technique enables high-resolution intravital imaging over multiple hours.
Exploring Three ASX Growth Companies With High Insider Ownership
Simply Wall St. via Yahoo Finance· 18 hours agoThe Australian stock market recently exhibited a positive trend, with the ASX200 closing up by 0.8%...
Renovaro teams up with Amsterdam UMC for cancer therapy By Investing.com
Investing.com· 4 days agoRenovaro Inc. (NASDAQ: RENB), a biotechnology company, has announced a partnership with the...
Utechzone And Two Other Reliable Dividend Stocks To Consider
Simply Wall St. via Yahoo Finance· 24 hours agoAmidst a backdrop of fluctuating global markets, where the Nasdaq hits new highs and the Dow Jones...
Krystal Biotech (KRYS) Gains 36% Year to Date: Here's Why
Zacks via Yahoo Finance· 5 days agoShares of the commercial-stage biotechnology company, Krystal Biotech, Inc. KRYS, surged 36.5% year...
Aiming for New Quality Productivity, Aiding in Reaching the Summit of Global Innovative...
FOX 59 Indianapolis· 6 days agoOn May 22, 2024, NeoMab Biotechnology (Suzhou) Co., Ltd. celebrated its grand opening in Suzhou...
Eli Lilly and Co., partners with Boston biotech company to develop cancer treatment
Indianapolis Star via Yahoo News· 7 days agoEli Lilly and Co., is working with Boston-based biotechnology company, Aktis Oncology, to develop cancer treatment, Aktis announced Tuesday. As a part of the deal between ...